Genome-wide association study and targeted metabolomics identifies sex-specific association of CPS1 with coronary artery disease
Open accessThe DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
Metabolites derived from dietary choline and L-carnitine, such as trimethylamine N-oxide and betaine, have recently been identified as novel risk factors for atherosclerosis in mice and humans. We sought to identify genetic factors associated with plasma betaine levels and determine their effect on risk of coronary artery disease (CAD). A two-stage genome-wide association study (GWAS) identified two significantly associated loci on chromosomes 2q34 and 5q14.1. The lead variant on 2q24 (rs715) localizes to carbamoyl-phosphate synthase 1 (CPS1), which encodes a mitochondrial enzyme that catalyses the first committed reaction and rate-limiting step in the urea cycle. Rs715 is also significantly associated with decreased levels of urea cycle metabolites and increased plasma glycine levels. Notably, rs715 yield a strikingly significant and protective association with decreased risk of CAD in only women. These results suggest that glycine metabolism and/or the urea cycle represent potentially novel sex-specific mechanisms for the development of atherosclerosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“For certain disorders, metabolomics can also be used to bridge genotype to phenotype [28].”
From Multi-omics approaches to disease (2017) · cites this paper as [28]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PLINK: a tool set for whole-genome association and population-based linkage analyses.
Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M. A. R., Bender, D., Maller, J., Sklar, P., de Bakker, P. I. W., Daly, M. J., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/519795 · Cited by 34,089
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
Wang, Z., Klipfell, E., Bennett, B. J., Koeth, R., Levison, B. S., DuGar, B., Feldstein, A. E., Britt, E. B., Fu, X., Chung, Y.-M., et al. (2011) · Nature · doi:10.1038/nature09922 · Cited by 5,597
Self-citationIntestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis
Koeth, R. A., Wang, Z., Levison, B. S., Buffa, J. A., Org, E., Sheehy, B. T., Britt, E. B., Fu, X., Wu, Y., Li, L., et al. (2013) · Nature Medicine · doi:10.1038/nm.3145 · Cited by 4,386 · cited 2×
“Although the precise role of TMAO in physiological processes and atherogenesis is not entirely known, both it and FMO3 , the major enzyme responsible for generating TMAO 8 , have been linked to alterations in cholesterol and sterol metabolism 13,14 , as well as inflammatory gene expression 6,14 .”
Self-citationIntestinal microbial metabolism of phosphatidylcholine and cardiovascular risk
Tang, W. H. W., Wang, Z., Levison, B. S., Koeth, R. A., Britt, E. B., Fu, X., Wu, Y., & Hazen, S. L. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1109400 · Cited by 3,400 · cited 2×
“In parallel, dietary choline can also be absorbed by the intestine and oxidized to betaine in the liver (and kidney) via a two-step process involving choline dehydrogenase ( CHDH ) and aldehyde dehydrogenase 7 family member A1 ( ALDH7A1 ) 11,12 .”
Self-citationWiller (2013) · doi:10.1038/ng.2797 · Cited by 2,983
A comprehensive 1000 Genomes–based genome-wide association meta-analysis of coronary artery disease
the CARDIoGRAMplusC4D Consortium (2015) · Nature Genetics · doi:10.1038/ng.3396 · Cited by 2,447
Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease
Cardiogenics, Schunkert, H., the CARDIoGRAM Consortium, König, I. R., Kathiresan, S., Reilly, M. P., Assimes, T. L., Holm, H., Preuss, M., Stewart, A. F. R., et al. (2011) · Nature Genetics · doi:10.1038/ng.784 · Cited by 1,866
Self-citationAn atlas of genetic influences on human blood metabolites
The Multiple Tissue Human Expression Resource (MuTHER) Consortium, Shin, S.-Y., Fauman, E. B., Petersen, A.-K., Krumsiek, J., Santos, R., Huang, J., Arnold, M., Erte, I., Forgetta, V., et al. (2014) · Nature Genetics · doi:10.1038/ng.2982 · Cited by 1,515
Bennett, B. J., Vallim, T. Q. D. A., Wang, Z., Shih, D. M., Meng, Y., Gregory, J., Allayee, H., Lee, R., Graham, M., Crooke, R., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2012.12.011 · Cited by 1,070 · cited 9×
“Although the precise role of TMAO in physiological processes and atherogenesis is not entirely known, both it and FMO3 , the major enzyme responsible for generating TMAO 8 , have been linked to alterations in cholesterol and sterol metabolism 13,14 , as well as inflammatory gene expression 6,14 .”
InfluentialSelf-citationHuman metabolic individuality in biomedical and pharmaceutical research
CARDIoGRAM, Suhre, K., Shin, S.-Y., Petersen, A.-K., Mohney, R. P., Meredith, D., Wägele, B., Altmaier, E., Deloukas, P., Erdmann, J., et al. (2011) · Nature · doi:10.1038/nature10354 · Cited by 1,017 · cited 1×
“Interestingly, two other previous GWAS identified a different CPS1 variant (rs2216405) for plasma glycine levels 16,17 , which is in moderate LD with rs1047891 and rs715 in subjects of northern European ancestry ( r 2 B 0.42).”
InfluentialSelf-citationMapping the Genetic Architecture of Gene Expression in Human Liver
Schadt, E. E., Molony, C., Chudin, E., Hao, K., Yang, X., Lum, P. Y., Kasarskis, A., Zhang, B., Wang, S., Suver, C., et al. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060107 · Cited by 921 · cited 1×
“1 variants in previously published hepatic gene expression data sets, at least based on the thresholds selected for genome-wide significance in these prior analyses 21–24 .”
New loci associated with kidney function and chronic kidney disease
Köttgen, A., Pattaro, C., Böger, C. A., Fuchsberger, C., Olden, M., Glazer, N. L., Parsa, A., Gao, X., Yang, Q., Smith, A. V., et al. (2010) · Nature Genetics · doi:10.1038/ng.568 · Cited by 804
Glycine metabolism in animals and humans: implications for nutrition and health
Wang, W., Wu, Z., Dai, Z., Yang, Y., Wang, J., & Wu, G. (2013) · Amino Acids · doi:10.1007/s00726-013-1493-1 · Cited by 766 · cited 1×
“In this regard, glycine has been shown to have cardioprotective anti-inflammatory properties in endothelial cells, activated macrophages and other leukocytes 46,47 , thus providing another possible mechanism for how a genetic factor that increases glycine levels reduces risk of CAD.”
A genome-wide perspective of genetic variation in human metabolism
Illig, T., Gieger, C., Zhai, G., Römisch-Margl, W., Wang-Sattler, R., Prehn, C., Altmaier, E., Kastenmüller, G., Kato, B. S., Mewes, H.-W., et al. (2010) · Nature Genetics · doi:10.1038/ng.507 · Cited by 653 · cited 1×
“Interestingly, two other previous GWAS identified a different CPS1 variant (rs2216405) for plasma glycine levels 16,17 , which is in moderate LD with rs1047891 and rs715 in subjects of northern European ancestry ( r 2 B 0.42).”
InfluentialSystems genetics approaches to understand complex traits
Civelek, M., & Lusis, A. J. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3575 · Cited by 621 · cited 1×
“Furthermore, systems genetics analyses that combine metabolic profiles with genomic, transcriptomic, proteomic and clinical data have yielded comprehensive data sets that can potentially be leveraged to identify underlying biological networks that drive disease susceptibility 4 .”
Krueger, S. K., & Williams, D. E. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.01.001 · Cited by 567
Wang, Z., Tang, W. H. W., Buffa, J. A., Fu, X., Britt, E. B., Koeth, R. A., Levison, B. S., Fan, Y., Wu, Y., & Hazen, S. L. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu002 · Cited by 559 · cited 1×
“Furthermore, a recent analysis showed that neither choline nor betaine predicted incident cardiac events when plasma TMAO levels were added to the adjustment model, and that choline and betaine predicted future risk of adverse events only in the context of elevated TMAO levels 44 .”
Self-citationBhattacharyya, T. (2008) · JAMA · doi:10.1001/jama.299.11.1265 · Cited by 533 · cited 1×
“The GeneBank Study has been used previously for discovery and replication of novel genes and risk factors for atherosclerotic disease 49–53 .”
The clinical significance of betaine, an osmolyte with a key role in methyl group metabolism
Lever, M., & Slow, S. (2010) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2010.03.009 · Cited by 460
The TMAO-Generating Enzyme Flavin Monooxygenase 3 Is a Central Regulator of Cholesterol Balance
Warrier, M., Shih, D. M., Burrows, A. C., Ferguson, D., Gromovsky, A. D., Brown, A. L., Marshall, S., McDaniel, A., Schugar, R. C., Wang, Z., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2014.12.036 · Cited by 414
Self-citationDiscovery of Sexual Dimorphisms in Metabolic and Genetic Biomarkers
Mittelstrass, K., Ried, J. S., Yu, Z., Krumsiek, J., Gieger, C., Prehn, C., Roemisch-Margl, W., Polonikov, A., Peters, A., Theis, F. J., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002215 · Cited by 383 · cited 2×
“Although these results are consistent with prior studies 18–20,25 –27 , we additionally demonstrated that rs715 was associated with decreased levels of Glycine is the downstream product of progressive betaine demethylation and one metabolite that is degraded to NH 3 for subsequent entry into the…”
Glycine cleavage system: reaction mechanism, physiological significance, and hyperglycinemia
KIKUCHI, G., MOTOKAWA, Y., YOSHIDA, T., & HIRAGA, K. (2008) · Proceedings of the Japan Academy, Series B · doi:10.2183/pjab.84.246 · Cited by 375
Shih, D. M., Wang, Z., Lee, R., Meng, Y., Che, N., Charugundla, S., Qi, H., Wu, J., Pan, C., Brown, J. M., et al. (2015) · Journal of Lipid Research · doi:10.1194/jlr.m051680 · Cited by 335 · cited 1×
“Although the precise role of TMAO in physiological processes and atherogenesis is not entirely known, both it and FMO3 , the major enzyme responsible for generating TMAO 8 , have been linked to alterations in cholesterol and sterol metabolism 13,14 , as well as inflammatory gene expression 6,14 .”
Self-citationA Genome-wide Association Study of the Human Metabolome in a Community-Based Cohort
Rhee, E. P., Ho, J. E., Chen, M.-H., Shen, D., Cheng, S., Larson, M. G., Ghorbani, A., Shi, X., Helenius, I. T., O’Donnell, C. J., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.06.013 · Cited by 321 · cited 1×
“We suspect that this is unlikely as the Twins UK, KORA and Framingham Heart Study cohorts reported directionally consistent associations between rs16876394, rs557302 and rs617219 with plasma betaine levels but not with other pathway intermediates 19,20 .”
Wang, Z., Levison, B. S., Hazen, J. E., Donahue, L., Li, X.-M., & Hazen, S. L. (2014) · Analytical Biochemistry · doi:10.1016/j.ab.2014.03.016 · Cited by 320 · cited 1×
“With respect to coronary artery disease (CAD), this has led to the identification of metabolites in several pathways that may serve as novel clinical biomarkers 1–3 .”
Self-citationBetaine: a key modulator of one-carbon metabolism and homocysteine status
Ueland, P. M., Holm, P. I., & Hustad, S. (2005) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2005.187 · Cited by 265 · cited 1×
“In parallel, dietary choline can also be absorbed by the intestine and oxidized to betaine in the liver (and kidney) via a two-step process involving choline dehydrogenase ( CHDH ) and aldehyde dehydrogenase 7 family member A1 ( ALDH7A1 ) 11,12 .”
Tang, W. H. W., Wang, Z., Cho, L., Brennan, D. M., & Hazen, S. L. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.02.036 · Cited by 221
Self-citationBetaine homocysteine S-methyltransferase: just a regulator of homocysteine metabolism?
Pajares, M. A., & Pérez-Sala, D. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-006-6249-6 · Cited by 207 · cited 1×
“By comparison, betaine provides one source of methyl groups required for the conversion of homocysteine to methionine, as well the being a methyl donor in folate metabolism 15 .”
Innocenti, F., Cooper, G. M., Stanaway, I. B., Gamazon, E. R., Smith, J. D., Mirkov, S., Ramirez, J., Liu, W., Lin, Y. S., Moloney, C., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002078 · Cited by 204
van Meurs, J. B., Pare, G., Schwartz, S. M., Hazra, A., Tanaka, T., Vermeulen, S. H., Cotlarciuc, I., Yuan, X., Mälarstig, A., Bandinelli, S., et al. (2013) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.044545 · Cited by 198
Self-citationTang, W. H. W., Hartiala, J., Fan, Y., Wu, Y., Stewart, A. F. R., Erdmann, J., Kathiresan, S., The CARDIoGRAM Consortium, Roberts, R., McPherson, R., et al. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.112.253930 · Cited by 174
Self-citationA survey of the genetics of stomach, liver, and adipose gene expression from a morbidly obese cohort
Greenawalt, D. M., Dobrin, R., Chudin, E., Hatoum, I. J., Suver, C., Beaulaurier, J., Zhang, B., Castro, V., Zhu, J., Sieberts, S. K., et al. (2011) · Genome Research · doi:10.1101/gr.112821.110 · Cited by 165
Hasegawa, S., Ichiyama, T., Sonaka, I., Ohsaki, A., Okada, S., Wakiguchi, H., Kudo, K., Kittaka, S., Hara, M., & Furukawa, S. (2012) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2011.04519.x · Cited by 156
Choe, C.-U., Atzler, D., Wild, P. S., Carter, A. M., Böger, R. H., Ojeda, F., Simova, O., Stockebrand, M., Lackner, K., Nabuurs, C., et al. (2013) · Circulation · doi:10.1161/circulationaha.112.000580 · Cited by 143 · cited 1×
“For example, the minor alleles of rs715 and rs1047891 have been associated with other CAD-related traits, including increased homocysteine 34–37 and creatinine levels 38 , but decreased homoarginine 39,40 , high-density lipoprotein 41 , and fibrinogen levels 42,43 .”
Sabater-Lleal, M., Huang, J., Chasman, D., Naitza, S., Dehghan, A., Johnson, A. D., Teumer, A., Reiner, A. P., Folkersen, L., Basu, S., et al. (2013) · Circulation · doi:10.1161/circulationaha.113.002251 · Cited by 141
Hartiala, J., Bennett, B. J., Tang, W. H. W., Wang, Z., Stewart, A. F. R., Roberts, R., McPherson, R., Lusis, A. J., Hazen, S. L., & Allayee, H. (2014) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.114.303252 · Cited by 133 · cited 2×
“1 were associated with plasma betaine levels in stage 1 at the significant ( P o 5.0 (cid:2) 10 (cid”
InfluentialSelf-citationGenetic Determinants Influencing Human Serum Metabolome among African Americans
Yu, B., Zheng, Y., Alexander, D., Morrison, A. C., Coresh, J., & Boerwinkle, E. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004212 · Cited by 104
Schröder, A., Klein, K., Winter, S., Schwab, M., Bonin, M., Zell, A., & Zanger, U. M. (2013) · The Pharmacogenomics Journal · doi:10.1038/tpj.2011.44 · Cited by 104 · cited 1×
“1 variants in previously published hepatic gene expression data sets, at least based on the thresholds selected for genome-wide significance in these prior analyses 21–24 .”
Paré, G., Chasman, D. I., Parker, A. N., Zee, R. R. Y., Mälarstig, A., Seedorf, U., Collins, R., Watkins, H., Hamsten, A., Miletich, J. P., et al. (2009) · Circulation: Cardiovascular Genetics · doi:10.1161/circgenetics.108.829804 · Cited by 102 · cited 1×
“1 or 2 Vessels (%) 3,330 (38) Z3 Vessels (%) 2,942 (34) BMI (kgm 2) 29.”
Toward New Biomarkers of Cardiometabolic Diseases
Roberts, L. D., & Gerszten, R. E. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.05.009 · Cited by 89 · cited 1×
“With respect to coronary artery disease (CAD), this has led to the identification of metabolites in several pathways that may serve as novel clinical biomarkers 1–3 .”
Danik, J. S., Paré, G., Chasman, D. I., Zee, R. Y. L., Kwiatkowski, D. J., Parker, A., Miletich, J. P., & Ridker, P. M. (2009) · Circulation: Cardiovascular Genetics · doi:10.1161/circgenetics.108.825273 · Cited by 86
Xie, W., Wood, A. R., Lyssenko, V., Weedon, M. N., Knowles, J. W., Alkayyali, S., Assimes, T. L., Quertermous, T., Abbasi, F., Paananen, J., et al. (2013) · Diabetes · doi:10.2337/db12-0876 · Cited by 83 · cited 1×
“Although these results are consistent with prior studies 18–20,25 –27 , we additionally demonstrated that rs715 was associated with decreased levels of Glycine is the downstream product of progressive betaine demethylation and one metabolite that is degraded to NH 3 for subsequent entry into the…”
Williams, S. R., Yang, Q., Chen, F., Liu, X., Keene, K. L., Jacques, P., Chen, W.-M., Weinstein, G., Hsu, F.-C., Beiser, A., et al. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004214 · Cited by 78
Insight in Genome-Wide Association of Metabolite Quantitative Traits by Exome Sequence Analyses
Demirkan, A., Henneman, P., Verhoeven, A., Dharuri, H., Amin, N., van Klinken, J. B., Karssen, L. C., de Vries, B., Meissner, A., Göraler, S., et al. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1004835 · Cited by 76 · cited 1×
“Although these results are consistent with prior studies 18–20,25 –27 , we additionally demonstrated that rs715 was associated with decreased levels of Glycine is the downstream product of progressive betaine demethylation and one metabolite that is degraded to NH 3 for subsequent entry into the…”
Lange, L. A., Croteau-Chonka, D. C., Marvelle, A. F., Qin, L., Gaulton, K. J., Kuzawa, C. W., McDade, T. W., Wang, Y., Li, Y., Levy, S., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq062 · Cited by 69
Relationship Between Carbamoyl-Phosphate Synthetase Genotype and Systemic Vascular Function
Summar, M. L., Gainer, J. V., Pretorius, M., Malave, H., Harris, S., Hall, L. D., Weisberg, A., Vaughan, D. E., Christman, B. W., & Brown, N. J. (2004) · Hypertension · doi:10.1161/01.hyp.0000112424.06921.52 · Cited by 65
Kleber, M. E., Seppälä, I., Pilz, S., Hoffmann, M. M., Tomaschitz, A., Oksala, N., Raitoharju, E., Lyytikäinen, L., Mäkelä, K.-M., Laaksonen, R., et al. (2013) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.113.000108 · Cited by 65
Clinical and Genetic Association of Serum Ceruloplasmin With Cardiovascular Risk
Wilson Tang, W. H., Wu, Y., Hartiala, J., Fan, Y., Stewart, A. F. R., Roberts, R., McPherson, R., Fox, P. L., Allayee, H., & Hazen, S. L. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.237040 · Cited by 64
Self-citationFreeman, J. M. (1970) · Archives of Neurology · doi:10.1001/archneur.1970.00480290050006 · Cited by 57 · cited 2×
“This notion would also be consistent with the hyperglycinemia observed in CPS1 -deficient patients 33 .”
Genetic contribution of the leukotriene pathway to coronary artery disease
Hartiala, J., Li, D., Conti, D. V., Vikman, S., Patel, Y. M., Tang, W. H. W., Brennan, M.-L., Newman, J. W. I., Stephensen, C. B., Armstrong, P., et al. (2011) · Human Genetics · doi:10.1007/s00439-011-0963-3 · Cited by 51
Self-citationRodríguez-Aparicio, L. B., Guadalajara, A. M., & Rubio, V. (1989) · Biochemistry · doi:10.1021/bi00433a050 · Cited by 45
Senkevitch, E., Cabrera‐Luque, J., Morizono, H., Caldovic, L., & Tuchman, M. (2012) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2012.03.004 · Cited by 24
Reiner, A. P., Hartiala, J., Zeller, T., Bis, J. C., Dupuis, J., Fornage, M., Baumert, J. J., Kleber, M. E., Wild, P. S., Baldus, S. E., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt189 · Cited by 23 · cited 1×
“The GeneBank Study has been used previously for discovery and replication of novel genes and risk factors for atherosclerotic disease 49–53 .”
Self-citationA structure‐reactivity study of the binding of acetylglutamate to carbamoyl phosphate synthetase I
Britton, H. G., García‐España, A., Goya, P., Rozas, I., & Rubio, V. (1990) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1990.tb15369.x · Cited by 18
Cited by
Multi-omics approaches to disease
Hasin, Y., Seldin, M., & Lusis, A. (2017) · Genome Biology · doi:10.1186/s13059-017-1215-1 · Cited by 2,953
Alseekh, S., Aharoni, A., Brotman, Y., Contrepois, K., D’Auria, J., Ewald, J., C. Ewald, J., Fraser, P. D., Giavalisco, P., Hall, R. D., et al. (2021) · Nature Methods · doi:10.1038/s41592-021-01197-1 · Cited by 1,128
Liu, X., & Locasale, J. W. (2017) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2017.01.004 · Cited by 453
Identification of type 2 diabetes loci in 433,540 East Asian individuals
Spracklen, C. N., Horikoshi, M., Kim, Y. J., Lin, K., Bragg, F., Moon, S., Suzuki, K., Tam, C. H. T., Tabara, Y., Kwak, S.-H., et al. (2020) · Nature · doi:10.1038/s41586-020-2263-3 · Cited by 440
Gender medicine: effects of sex and gender on cardiovascular disease manifestation and outcomes
Regitz-Zagrosek, V., & Gebhard, C. (2023) · Nature Reviews Cardiology · doi:10.1038/s41569-022-00797-4 · Cited by 386
Metadata
- Authors
- Hartiala, J. A., Wilson Tang, W. H., Wang, Z., Crow, A. L., Stewart, A. F. R., Roberts, R., McPherson, R., Erdmann, J., Willenborg, C., Hazen, S. L., & Allayee, H.
- Affiliations
- University of Southern California (US)
- Cleveland Clinic (US)
- Ottawa Heart Institute (CA)
- Institute for Integrative and Experimental Genomics (DE)
- Corresponding author
- Allayee, Hooman
- ORCID
- Venue
- Nature Communications
- Published
- 2016-01-29
- Volume
- 7
- Issue
- 1
- Pages
- 10558-10558
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC4740183
- OpenAlex
- W2299824834
- Cited by
- 130
- References
- 54
- Citations by year
- 2026: 7 · 2025: 13 · 2024: 6 · 2023: 9 · 2022: 15 · 2021: 15 · 2020: 12 · 2019: 18 · 2018: 16 · 2017: 13 · 2016: 6
- FWCI
- 14.26
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- UA Campus Repository (The University of Arizona) (acceptedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- American Heart Association (12SDG12050473)
- Cleveland Clinic
- Fondation Leducq
- National Institutes of Health
- Canadian Institutes of Health Research (MOT82810)
- National Heart, Lung, and Blood Institute (R01HL103931, P20HL113452, P01HL076491, P01HL098055, R01HL103866)
- National Institute of Environmental Health Sciences (R01ES025786, R01ES021801, P30ES007048)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
- Keywords
- coronary artery disease, CPS1, sex differences, atherosclerosis, betaine, urea cycle, glycine metabolism, trimethylamine N-oxide, L-carnitine, choline metabolites, plasma metabolites, genetic susceptibility loci
- MeSH terms
- Betaine, Carbamoyl-Phosphate Synthase (Ammonia), Coronary Disease, Female, Genotype, Humans, Male, Sex Factors, Gene Expression Regulation, Enzymologic, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Genome-Wide Association Study, Metabolomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.